Fox News: New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Merck's Diabetes Medicine, and Metformin through Two Years of Treatment

[riky]

New Data Released at Major Diabetes Meeting on Initial Combination Therapy with JANUVIA(TM) (sitagliptin), Merck's Diabetes Medicine, and Metformin through Two Years of Treatment
     

Combination Of JANUVIA, First and Only DPP-4 Inhibitor in United
   States, with Metformin Improved Markers of Beta Cell Function and
    Provided Significant Glucose-Lowering at One Year and Two Years<img src="You are not allowed to view links. Register or Login" height="1" width="1"/><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
     

You are not allowed to view links. Register or Login